Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hepion Pharmaceuticals ( (HEPA) ) just unveiled an announcement.
On April 21, 2026, Hepion Pharmaceuticals, Inc. entered into securities purchase agreements with accredited investors for a private placement of 17,500,000 shares of common stock at $0.04 per share, generating gross proceeds of $700,000. The offering, which closed the same day, was conducted under exemptions from U.S. securities registration requirements and included customary contractual protections and obligations for both the company and investors.
More about Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapies, with its shares of common stock traded in the U.S. capital markets. The company raises capital periodically through equity offerings to fund its operations and advance its clinical and corporate initiatives within the healthcare and life sciences sector.
Average Trading Volume: 13,378
Technical Sentiment Signal: Strong Sell
Current Market Cap: $423K
Learn more about HEPA stock on TipRanks’ Stock Analysis page.